Mark Borden
The collaborative work could boost health and drug advancements by giving researchers a better understanding of primary and secondary radiation forces in multiphase colloidal systems – such as emulsions, foams, membranes and gels.
After a year when the nation experienced a shortage of mechanical ventilators to help treat patients with severe COVID-19 complications, Professor Mark Borden's company Respirogen presents another treatment option: oxygen microbubbles.
John Myers (MBioEngr’21) was the first student to graduate from the Biomedical Engineering Program with a thesis-based master’s degree. Now, he has a more competitive edge as he plans his future education and career.
Two faculty members with the Biomedical Engineering Program have received grants from the Colorado Clinical and Translational Science Institute (CCTSI). CCTSI awarded BME Program Director Mark Borden and Associate Professor Virginia Ferguson two
